John Sivesind
Corneal and Contact Management · Sioux Falls, SDNPI 1285672246
Payments from drug & device makers
Across 20 payments — averaging $78.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$1K
- Alcon Research LLC$285
- Coopervision Inc.$121
- Johnson & Johnson Vision Care, Inc.$75
- Bausch & Lomb Americas Inc.$44
- Biotissue Holdings Inc.$14
Across 1 payment — averaging $108.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$109
What the payments were for
- Consulting fees$28518%
- Speaking & faculty fees$1,00063%
- Food & beverage$29118%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 6 | $1,037 |
| Alcon Research LLC | 1 | $285 |
| Coopervision Inc. | 7 | $121 |
| Johnson & Johnson Vision Care, Inc. | 2 | $75 |
| Bausch & Lomb Americas Inc. | 3 | $44 |
| Biotissue Holdings Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DAILIES TOTAL1$1,000
- Precision 1$1,000
- DAILIES TOTAL1 Multifocal$667
- TOTAL30$667
- Dailies Aqua Comfort Plus$333
- AIR OPTIX$333
- Air Optix plus HydraGlyde$333
How this compares
Too few corneal and contact management providers in South Dakotato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CombiganBrimonidine Tartrate/Timolol | 14 | $4,223 |
| Latanoprost | 52 | $462 |
| Prednisolone Acetate | 11 | $304 |
| Timolol Maleate | 15 | $98 |
Paid to pharmacies, not to this prescriber.
Other corneal and contact management in Sioux Falls
- Gary KotsRosebud$381
- Brad MoriartyRapid City$321
- Melanie CulveyRapid City$90
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.